Cost-benefit analysis of lipid lowering therapy

Eur Heart J. 1996 Jul;17(7):974-5. doi: 10.1093/oxfordjournals.eurheartj.a015014.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Humans
  • Hyperlipidemias / drug therapy
  • Hyperlipidemias / economics*
  • Hypolipidemic Agents / economics*
  • Hypolipidemic Agents / therapeutic use
  • Lovastatin / analogs & derivatives*
  • Lovastatin / economics
  • Lovastatin / therapeutic use
  • Simvastatin
  • Sweden

Substances

  • Hypolipidemic Agents
  • Lovastatin
  • Simvastatin